106 related articles for article (PubMed ID: 23154603)
1. Predictive tools for prostate cancer staging, treatment response and outcomes.
Green DA; Osterberg EC; Xylinas E; Rink M; Karakiewicz PI; Scherr DS; Shariat SF
Arch Esp Urol; 2012 Nov; 65(9):787-807. PubMed ID: 23154603
[TBL] [Abstract][Full Text] [Related]
2. Inventory of prostate cancer predictive tools.
Shariat SF; Karakiewicz PI; Margulis V; Kattan MW
Curr Opin Urol; 2008 May; 18(3):279-96. PubMed ID: 18382238
[TBL] [Abstract][Full Text] [Related]
3. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.
Shariat SF; Abdel-Aziz KF; Roehrborn CG; Lotan Y
Eur Urol; 2006 Feb; 49(2):293-302. PubMed ID: 16387412
[TBL] [Abstract][Full Text] [Related]
4. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy.
Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
Urology; 2004 Dec; 64(6):1165-70. PubMed ID: 15596191
[TBL] [Abstract][Full Text] [Related]
5. Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.
Wang L; Hricak H; Kattan MW; Schwartz LH; Eberhardt SC; Chen HN; Scardino PT
AJR Am J Roentgenol; 2006 Mar; 186(3):743-8. PubMed ID: 16498101
[TBL] [Abstract][Full Text] [Related]
6. Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy.
Donovan MJ; Hamann S; Clayton M; Khan FM; Sapir M; Bayer-Zubek V; Fernandez G; Mesa-Tejada R; Teverovskiy M; Reuter VE; Scardino PT; Cordon-Cardo C
J Clin Oncol; 2008 Aug; 26(24):3923-9. PubMed ID: 18711180
[TBL] [Abstract][Full Text] [Related]
7. Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.
Salonia A; Gallina A; Briganti A; Zanni G; Suardi N; Capitanio U; Colombo R; Bertini R; Freschi M; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2011 Apr; 107(8):1243-9. PubMed ID: 20883480
[TBL] [Abstract][Full Text] [Related]
8. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD
Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714
[TBL] [Abstract][Full Text] [Related]
10. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.
Walz J; Chun FK; Klein EA; Reuther A; Saad F; Graefen M; Huland H; Karakiewicz PI
J Urol; 2009 Feb; 181(2):601-7; discussion 607-8. PubMed ID: 19084864
[TBL] [Abstract][Full Text] [Related]
11. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.
Naito S; Kuroiwa K; Kinukawa N; Goto K; Koga H; Ogawa O; Murai M; Shiraishi T;
J Urol; 2008 Sep; 180(3):904-9; discussion 909-10. PubMed ID: 18635221
[TBL] [Abstract][Full Text] [Related]
12. Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer.
Johnson SB; Hamstra DA; Jackson WC; Zhou J; Foster B; Foster C; Song Y; Li D; Palapattu GS; Kunju L; Mehra R; Sandler H; Feng FY
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):275-81. PubMed ID: 23886418
[TBL] [Abstract][Full Text] [Related]
13. Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approaches.
Miyake H; Fujisawa M
Int J Urol; 2013 Mar; 20(3):301-11. PubMed ID: 23020893
[TBL] [Abstract][Full Text] [Related]
14. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
15. An updated catalog of prostate cancer predictive tools.
Shariat SF; Karakiewicz PI; Roehrborn CG; Kattan MW
Cancer; 2008 Dec; 113(11):3075-99. PubMed ID: 18823041
[TBL] [Abstract][Full Text] [Related]
16. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging.
Chen M; Hricak H; Kalbhen CL; Kurhanewicz J; Vigneron DB; Weiss JM; Carroll PR
AJR Am J Roentgenol; 1996 May; 166(5):1157-63. PubMed ID: 8615261
[TBL] [Abstract][Full Text] [Related]
17. The newer the better? Comparison of the 1997 and 2001 partin tables for pathologic stage prediction of prostate cancer in China.
Gao X; Ren S; Lu X; Xu C; Sun Y
Urology; 2008 Nov; 72(5):1096-101. PubMed ID: 18822453
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
Chun FK; Briganti A; Gallina A; Hutterer GC; Shariat SF; Antebie E; Walz J; Roehrborn CG; Salonia A; Rigatti P; Saad F; Huland H; Montorsi F; Graefen M; Karakiewicz PI
Eur Urol; 2007 Oct; 52(4):1067-74. PubMed ID: 17383807
[TBL] [Abstract][Full Text] [Related]
19. Phased array magnetic resonance imaging for staging clinically localised prostrate cancer.
Borre M; Lundorf E; Marcussen N; Langkilde NC; Wolf H
Acta Oncol; 2005; 44(6):589-92. PubMed ID: 16294442
[TBL] [Abstract][Full Text] [Related]
20. Role of surgery in treatment of locally advanced prostate cancer.
Prezioso D; Galasso R; Di Martino M; Iapicca G; Iacono F
Anticancer Res; 2006; 26(4B):3151-8. PubMed ID: 16886649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
